Data is not available at this time.
CareCloud, Inc. operates in the healthcare technology sector, providing cloud-based solutions for medical practices, hospitals, and health systems. The company’s core revenue model is driven by subscription-based software services, including electronic health records (EHR), practice management, and revenue cycle management (RCM) tools. These offerings streamline clinical workflows, enhance billing efficiency, and improve patient engagement, positioning CareCloud as a key player in the digital transformation of healthcare administration. The company serves a diverse clientele, ranging from small independent practices to larger healthcare networks, leveraging its scalable platform to adapt to varying operational needs. CareCloud competes in a fragmented but rapidly growing market, where demand for integrated, interoperable solutions is rising due to regulatory pressures and the shift toward value-based care. Its competitive edge lies in its user-friendly interfaces, robust analytics, and compliance with evolving healthcare standards, though it faces stiff competition from larger EHR vendors and niche specialists. The company’s ability to innovate and expand its service offerings will be critical in maintaining its market position amid increasing consolidation and technological advancements in the sector.
CareCloud reported revenue of $110.8 million for the period, with net income of $7.9 million, reflecting a turnaround from prior challenges. Diluted EPS stood at -$0.28, indicating lingering profitability pressures. Operating cash flow was robust at $20.6 million, supported by efficient working capital management, while capital expenditures were modest at -$1.7 million, suggesting disciplined investment in growth initiatives.
The company’s operating cash flow underscores its ability to generate liquidity from core operations, a positive signal for earnings sustainability. However, negative diluted EPS highlights ongoing margin compression, possibly due to competitive pricing or integration costs. Capital efficiency appears stable, with limited capex relative to cash flow, though reinvestment will be crucial to maintain technological competitiveness in the evolving healthcare IT landscape.
CareCloud maintains a conservative balance sheet, with $5.1 million in cash and equivalents and total debt of $3.5 million, reflecting low leverage. The net cash position provides flexibility for strategic investments or acquisitions. Shareholders’ equity is supported by retained earnings, though the absence of dividends aligns with the company’s focus on reinvesting profits for growth.
Revenue growth trends are not explicitly provided, but the company’s focus on SaaS-based healthcare solutions aligns with industry tailwinds. CareCloud does not currently pay dividends, prioritizing organic expansion and potential M&A to capture market share. Future growth will hinge on adoption of its platform and cross-selling opportunities within its existing client base.
With a modest market capitalization implied by its share count and financials, CareCloud’s valuation likely reflects its niche position and mixed profitability. Investors may weigh its cash flow generation against sector peers, though the negative EPS could temper near-term optimism. Market expectations likely center on execution in converting revenue growth to sustained profitability.
CareCloud’s strategic advantages include its cloud-native platform and focus on mid-market healthcare providers, a segment often underserved by larger competitors. The outlook depends on its ability to scale efficiently, innovate in analytics and interoperability, and navigate regulatory changes. Success in these areas could solidify its position as a consolidator in the fragmented healthcare IT space.
Company filings (CIK: 0001582982), inferred financials for FY 2024
show cash flow forecast
| Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |